Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases

BACKGROUND & AIMS: Concurrent fatty liver disease represents an emerging challenge in the care of individuals with autoimmune liver diseases (AILD). Therefore, we aimed to validate the ultrasound-based method of controlled-attenuation parameter (CAP) as a non-invasive tool to detect hepatic stea...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinmann, Silja, Hartl, Johannes, Weidemann, Sören, Füssel, Katja, Kroll, Claudia, Sebode, Marcial, Lohse, Ansgar Wilhelm, Schramm, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632533/
https://www.ncbi.nlm.nih.gov/pubmed/37954487
http://dx.doi.org/10.1016/j.jhepr.2023.100898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632533/
https://www.ncbi.nlm.nih.gov/pubmed/37954487
http://dx.doi.org/10.1016/j.jhepr.2023.100898

Ejemplares similares